Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy ...

Although Micron Technology has enjoyed a stellar run thanks to AI demand, an overlooked quant signal points to an ...

Doctors are suddenly warning against a cheap 'autism drug' being fast-tracked to ease certain symptoms of the condition.

Researchers at the University Hospital Bonn (UKB) and the University of Bonn have discovered how a small, naturally occurring RNA molecule in the kidney activates a mutated immune receptor, triggering ...

Researchers at the University Hospital Bonn (UKB) and the University of Bonn have discovered how a small, naturally occurring RNA molecule in the kidney activates a mutated immune receptor, triggering ...

Micron Technology, Inc. (NASDAQ:MU) is a Must-Watch AI Stocks on Wall Street. On October 27, Citi analyst Christopher Danely ...

What Happened? Shares of memory chips maker Micron (NYSE:MU) jumped 5.3% in the afternoon session after several positive ...

Merck and Eisai Provide Update on Phase 3 LEAP-012 Trial in Unresectable, Non-Metastatic Hepatocellular Carcinoma ...

Topline phase 3 results show that the novel nanobody gefurulimab is safe and effective for AChR-antibody-positive myasthenia gravis, but long-term results will be key.

As information zings from cell to cell inside the brain, bursts of electricity spur its transmission. At Cold Spring Harbor Laboratory (CSHL), scientists have turned their attention to the tiny pores ...